Merck Says S. Korea Should View FTA As Using Strength For Alliances
This article was originally published in PharmAsia News
Executive Summary
The South Korea free-trade agreement with the U.S. has prompted concerns in the Asian nation’s pharmaceutical industry, but U.S.-based Merck says it actually offers new opportunities.